The Impact of Neutrophil-to-Lymphocyte Ratio after Two Courses of Pembrolizumab for Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma.
Tomioka-Inagawa R, Nakane K, Enomoto T, Tomioka M, Taniguchi T, Ishida T, Ozawa K, Takagi K, Ito H, Takeuchi S, Kawase M, Kawase K, Kato D, Takai M, Iinuma K, Yokoi S, Nakano M, Koie T.
Tomioka-Inagawa R, et al. Among authors: nakano m.
Biomedicines. 2022 Jul 6;10(7):1609. doi: 10.3390/biomedicines10071609.
Biomedicines. 2022.
PMID: 35884914
Free PMC article.